Literature DB >> 19536110

Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.

Hung-Ming Wu1, Nian-Sheng Tzeng, Li Qian, Sung-Jen Wei, Xiaoming Hu, Shih-Heng Chen, Scott M Rawls, Patrick Flood, Jau-Shyong Hong, Ru-Band Lu.   

Abstract

Memantine shows clinically relevant efficacy in patients with Alzheimer's disease and Parkinson's disease. Most in vivo and in vitro studies attribute the neuroprotective effects of memantine to the blockade of N-methyl-D-aspartate (NMDA) receptor on neurons. However, it cannot be excluded that mechanisms other than NMDA receptor blockade may contribute to the neuroprotective effects of this compound. To address this question, primary midbrain neuron-glia cultures and reconstituted cultures were used, and lipopolysaccharide (LPS), an endotoxin from bacteria, was used to produce inflammation-mediated dopaminergic (DA) neuronal death. Here, we show that memantine exerted both potent neurotrophic and neuroprotective effects on DA neurons in rat neuron-glia cultures. The neurotrophic effect of memantine was glia dependent, as memantine failed to show any positive effect on DA neurons in neuron-enriched cultures. More specifically, it seems to be that astroglia, not microglia, are the source of the memantine-elicited neurotrophic effects through the increased production of glial cell line-derived neurotrophic factor (GDNF). Mechanistic studies showed that GDNF upregulation was associated with histone hyperacetylation by inhibiting the cellular histone deacetylase activity. In addition, memantine also displays neuroprotective effects against LPS-induced DA neuronal damage through its inhibition of microglia activation showed by both OX-42 immunostaining and reduction of pro-inflammatory factor production, such as extracellular superoxide anion, intracellular reactive oxygen species, nitric oxide, prostaglandin E(2), and tumor necrosis factor-alpha. These results suggest that the neuroprotective effects of memantine shown in our cell culture studies are mediated in part through alternative novel mechanisms by reducing microglia-associated inflammation and by stimulating neurotrophic factor release from astroglia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536110      PMCID: PMC3655438          DOI: 10.1038/npp.2009.64

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

Review 1.  Astrocytes as targets for neuroprotective drugs.

Authors:  Cynthia L Darlington
Journal:  Curr Opin Investig Drugs       Date:  2005-07

Review 2.  Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.

Authors:  Stuart A Lipton
Journal:  Nat Rev Drug Discov       Date:  2006-02       Impact factor: 84.694

3.  Amantadine and memantine induce the expression of the glial cell line-derived neurotrophic factor in C6 glioma cells.

Authors:  Anne-Sophie Caumont; Jean-Noël Octave; Emmanuel Hermans
Journal:  Neurosci Lett       Date:  2005-11-18       Impact factor: 3.046

Review 4.  Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.

Authors:  Michelle L Block; Jau-Shyong Hong
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

5.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Authors:  M S Finnin; J R Donigian; A Cohen; V M Richon; R A Rifkind; P A Marks; R Breslow; N P Pavletich
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

6.  Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration.

Authors:  Hantamalala Ralay Ranaivo; Jeffrey M Craft; Wenhui Hu; Ling Guo; Laura K Wing; Linda J Van Eldik; D Martin Watterson
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

7.  L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked striatal glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade.

Authors:  S M Rawls; J F McGinty
Journal:  J Neurochem       Date:  1997-04       Impact factor: 5.372

8.  Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.

Authors:  Zachary C Baquet; Paula C Bickford; Kevin R Jones
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

9.  Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement.

Authors:  Soon-Tae Lee; Kon Chu; Keun-Hwa Jung; Juhyun Kim; Eun-Hee Kim; Se-Jeong Kim; Dong-In Sinn; Song-Yi Ko; Manho Kim; Jae-Kyu Roh
Journal:  J Cereb Blood Flow Metab       Date:  2006-04       Impact factor: 6.200

10.  Specific regulation of rat glial cell line-derived neurotrophic factor gene expression by riluzole in C6 glioma cells.

Authors:  Anne-Sophie Caumont; Jean-Noël Octave; Emmanuel Hermans
Journal:  J Neurochem       Date:  2006-03-08       Impact factor: 5.372

View more
  61 in total

1.  Administration of memantine during ethanol withdrawal in neonatal rats: effects on long-term ethanol-induced motor incoordination and cerebellar Purkinje cell loss.

Authors:  Nirelia M Idrus; Nancy N H McGough; Edward P Riley; Jennifer D Thomas
Journal:  Alcohol Clin Exp Res       Date:  2010-11-10       Impact factor: 3.455

Review 2.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

3.  Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.

Authors:  Rozzy Finn; Attila D Kovács; David A Pearce
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

4.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

5.  Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Shiou-Lan Chen; Yun-Hsuan Chang; Po-See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; I Hui Lee; Kao Ching Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Alcohol Clin Exp Res       Date:  2018-05-17       Impact factor: 3.455

6.  Regulation of Human Brain Microvascular Endothelial Cell Adhesion and Barrier Functions by Memantine.

Authors:  Fei Wang; Zhirong Zou; Yi Gong; Dong Yuan; Xun Chen; Tao Sun
Journal:  J Mol Neurosci       Date:  2017-04-20       Impact factor: 3.444

Review 7.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

Review 8.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

9.  Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment.

Authors:  Xiaobo Wei; Huimin Gao; Jing Zou; Xu Liu; Dan Chen; Jinchi Liao; Yunqi Xu; Long Ma; Beisha Tang; Zhuohua Zhang; Xiang Cai; Kunling Jin; Ying Xia; Qing Wang
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

10.  Peripheral ammonia and blood brain barrier structure and function after methamphetamine.

Authors:  Nicole A Northrop; Laura E Halpin; Bryan K Yamamoto
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.